Elevated expression of HOXC-AS3/YBX1/HOXC8 occurs in NSCLC cells, and inhibition of their expression significantly suppresses cancer cell proliferation, migration and invasion, resulting in attenuated tumour growth and metastasis in vivo. Here, HOXC8 is linked to non-small cell lung carcinoma.